Literature DB >> 22843876

Tumor progression and metastasis: role of translational deregulation.

Zeina Nasr1, Jerry Pelletier.   

Abstract

Translation deregulation is implicated in cellular transformation. Aberrant flux through signalling pathways that impinge on the translation process and perturbations in the relative levels of key regulatory translation initiation factors has been documented in a variety of human cancer types. Recently, studies have demonstrated that translation deregulation also contributes to the metastatic phenotype through selective effects on the translation of mRNAs whose products are involved in various steps of metastasis including migration, invasion, angiogenesis, homing, and activation of survival loops at distal sites. Herein, we present the latest findings implicating perturbed translational control in the metastatic process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843876

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.

Authors:  Oshrat Attar-Schneider; Victoria Zismanov; Liat Drucker; Maya Gottfried
Journal:  Tumour Biol       Date:  2015-10-30

2.  A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Authors:  Annelise Carvalho; Jennifer Chu; Céline Meinguet; Robert Kiss; Guy Vandenbussche; Bernard Masereel; Johan Wouters; Alexander Kornienko; Jerry Pelletier; Véronique Mathieu
Journal:  Eur J Pharmacol       Date:  2017-03-18       Impact factor: 4.432

Review 3.  Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.

Authors:  Jerry Pelletier; Jeremy Graff; Davide Ruggero; Nahum Sonenberg
Journal:  Cancer Res       Date:  2015-01-15       Impact factor: 12.701

4.  Construction and Evaluation of Robust Interpretation Models for Breast Cancer Metastasis Prediction.

Authors:  Nahim Adnan; Maryam Zand; Tim H M Huang; Jianhua Ruan
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2022-06-03       Impact factor: 3.702

5.  Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility.

Authors:  Yong Teng; Pushpankur Ghoshal; Lambert Ngoka; Yun Mei; John K Cowell
Journal:  Carcinogenesis       Date:  2013-05-14       Impact factor: 4.944

6.  eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation.

Authors:  Yaguang Zhang; Ping Wang; Qian Zhang; Xiaomin Yao; Linjie Zhao; Yibin Liu; Xiaowei Liu; Rui Tao; Chuan Yu; Yuhao Li; Xiangrong Song; Shaohua Yao
Journal:  Oncotarget       Date:  2017-03-21

7.  Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?

Authors:  Marco Tafani; Bruna Pucci; Andrea Russo; Luana Schito; Laura Pellegrini; Giulietta A Perrone; Lidia Villanova; Luisa Salvatori; Linda Ravenna; Elisa Petrangeli; Matteo A Russo
Journal:  Front Pharmacol       Date:  2013-02-12       Impact factor: 5.810

8.  The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.

Authors:  Rossella Lucá; Michele Averna; Francesca Zalfa; Manuela Vecchi; Fabrizio Bianchi; Giorgio La Fata; Franca Del Nonno; Roberta Nardacci; Marco Bianchi; Paolo Nuciforo; Sebastian Munck; Paola Parrella; Rute Moura; Emanuela Signori; Robert Alston; Anna Kuchnio; Maria Giulia Farace; Vito Michele Fazio; Mauro Piacentini; Bart De Strooper; Tilmann Achsel; Giovanni Neri; Patrick Neven; D Gareth Evans; Peter Carmeliet; Massimiliano Mazzone; Claudia Bagni
Journal:  EMBO Mol Med       Date:  2013-09-16       Impact factor: 12.137

9.  Contrast enhanced computed tomography is indicative for angiogenesis pattern and display prognostic significance in breast cancer.

Authors:  Jianyi Li; Yang Zhang; Wenhai Zhang; Yang Gao; Shi Jia; Jiao Guo
Journal:  BMC Cancer       Date:  2014-09-15       Impact factor: 4.430

10.  Key contribution of eIF4H-mediated translational control in tumor promotion.

Authors:  Charlotte Vaysse; Céline Philippe; Yvan Martineau; Cathy Quelen; Corinne Hieblot; Claire Renaud; Yvan Nicaise; Aurore Desquesnes; Maria Pannese; Thomas Filleron; Ghislaine Escourrou; Malcolm Lawson; Robert C Rintoul; Marie Bernadette Delisle; Stéphane Pyronnet; Pierre Brousset; Hervé Prats; Christian Touriol
Journal:  Oncotarget       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.